| pubmed-article:7738663 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7738663 | lifeskim:mentions | umls-concept:C0034603 | lld:lifeskim |
| pubmed-article:7738663 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:7738663 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:7738663 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:7738663 | lifeskim:mentions | umls-concept:C1566673 | lld:lifeskim |
| pubmed-article:7738663 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7738663 | pubmed:dateCreated | 1995-6-5 | lld:pubmed |
| pubmed-article:7738663 | pubmed:abstractText | Antibody fragments labeled with a radiometal using bifunctional chelates generally undergo renal clearance followed by trapping of the metabolites, leading to high radiation doses to the kidneys. Copper-64-labeled BAT-2IT-1A3-F(ab')2 was recently reported to accumulate in colorectal tumors in an animal model, however, kidney uptake was also high. In this study, the preparation of 64Cu-BAT-2IT-1A3-F(ab')2 was optimized to reduce the renal uptake. | lld:pubmed |
| pubmed-article:7738663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7738663 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7738663 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7738663 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7738663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7738663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7738663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7738663 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7738663 | pubmed:month | May | lld:pubmed |
| pubmed-article:7738663 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:PhilpottG WGW | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:MearesC FCF | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:AndersonC JCJ | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:ConnettJ MJM | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:ZinnK RKR | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:GuoL WLW | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:SchwarzS WSW | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:CutlerP DPD | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:GermainC JCJ | lld:pubmed |
| pubmed-article:7738663 | pubmed:author | pubmed-author:GreinerD PDP | lld:pubmed |
| pubmed-article:7738663 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7738663 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:7738663 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7738663 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:7738663 | pubmed:pagination | 850-8 | lld:pubmed |
| pubmed-article:7738663 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:meshHeading | pubmed-meshheading:7738663-... | lld:pubmed |
| pubmed-article:7738663 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7738663 | pubmed:articleTitle | Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. | lld:pubmed |
| pubmed-article:7738663 | pubmed:affiliation | Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA. | lld:pubmed |
| pubmed-article:7738663 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7738663 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7738663 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7738663 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7738663 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7738663 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7738663 | lld:pubmed |
